Winston Operating Cycle from 2010 to 2026
| WPHM Stock | USD 0.0003 0.00 0.00% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 11.45 | Current Value 10.88 | Quarterly Volatility 8.4424486 |
Check Winston Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Winston Pharmaceuticals' main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 1.5 M, as well as many indicators such as Price To Sales Ratio of 8.02, Dividend Yield of 0.0 or PTB Ratio of 10.66. Winston financial statements analysis is a perfect complement when working with Winston Pharmaceuticals Valuation or Volatility modules.
Winston | Operating Cycle | Build AI portfolio with Winston Stock |
Evaluating Winston Pharmaceuticals's Operating Cycle across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Winston Pharmaceuticals's fundamental strength.
Latest Winston Pharmaceuticals' Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of Winston Pharmaceuticals over the last few years. It is Winston Pharmaceuticals' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Winston Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
Winston Operating Cycle Regression Statistics
| Arithmetic Mean | 12.15 | |
| Geometric Mean | 11.03 | |
| Coefficient Of Variation | 69.46 | |
| Mean Deviation | 3.85 | |
| Median | 9.96 | |
| Standard Deviation | 8.44 | |
| Sample Variance | 71.27 | |
| Range | 34.9186 | |
| R-Value | (0.38) | |
| Mean Square Error | 64.85 | |
| R-Squared | 0.15 | |
| Significance | 0.13 | |
| Slope | (0.64) | |
| Total Sum of Squares | 1,140 |
Winston Operating Cycle History
About Winston Pharmaceuticals Financial Statements
Winston Pharmaceuticals investors utilize fundamental indicators, such as Operating Cycle, to predict how Winston Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 11.45 | 10.88 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Winston Pharmaceuticals Correlation against competitors. To learn how to invest in Winston Stock, please use our How to Invest in Winston Pharmaceuticals guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Will Drug Manufacturers - Specialty & Generic sector continue expanding? Could Winston diversify its offerings? Factors like these will boost the valuation of Winston Pharmaceuticals. Anticipated expansion of Winston directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Winston Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Winston Pharmaceuticals is measured differently than its book value, which is the value of Winston that is recorded on the company's balance sheet. Investors also form their own opinion of Winston Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Winston Pharmaceuticals' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Winston Pharmaceuticals' market value can be influenced by many factors that don't directly affect Winston Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Winston Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Winston Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Winston Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.